Ing. Lukáš Wagenknecht
Twitter
AKTIVNÍ
Obsah příspěvku
Aducanumab was approved by the FDA for use in Alzheimer's disease. Watch Ian M. Grant, MD, discuss its effectiveness, clinical impact, and indication and describe essential considerations for neurologists and their patients.
https://t.co/hDyRIQdCsm https://t.co/nA7acrSCQz
Screenshot
Screenshot není k dispozici
Metadata
| Platforma | Twitter (social) |
| Publikováno | 20.01.2022 17:10 |
| První viděn | 12.04.2026 08:36 |
| Poslední kontrola | 15.04.2026 04:08 |
| Počet slov | 0 |
| Hlídač ID | bb801847879fb6f90aede91319d35139 |
| Original ID | 1484211624592523266 |
| Zdrojová URL | https://twitter.com/WagenknechtLuk/status/1484211624592523266 |